DUETACT |
U-72107 |
ACTOS |
AD-4833 |
PIOGLITAZONE |
(+-)-5-((4-(2-(5-ETHYL-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-2,4-THIAZOLIDINEDIONE |
PIOGLITAZONA |
U-72107A |
5-{4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]BENZYL}-1,3-THIAZOLIDINE-2,4-DIONE |
XAB907 |
ZACTOS |
PIOGLITAZONUM |
chemidplus:111025-46-8 |
drugbank:01132 |
pubchem.compound:4829 |
rxcui:33738 |
chembl:CHEMBL595 |
Year of Approval | 1999 |
Drug Class | hypoglycemic agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antidiabetic |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inducers |
Drug Categories | cytochrome p-450 cyp3a4 inducers (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | hypoglycemia-associated agents |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | oatp1b3 inhibitors |
Drug Categories | peroxisome proliferator receptor gamma agonist |
Drug Categories | peroxisome proliferator-activated receptor activity |
Drug Categories | thiazolidinediones |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | True |
blocker (inhibitory) |
Specific Action of the Ligand | None |
Details of Interaction | independent of PPAR-γ |
Endogenous Drug? | False |
Act Pioglitazone | Drug Brand |
Actoplus Met | Drug Brand |
Actoplus Met XR | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
PIOGLITAZONE | Primary Drug Name |
Drug Class | hypoglycemic agents |
Year of Approval | 1999 |
Drug Indications | antidiabetic |
Drug Class | Small Molecule |
FDA Approval | approved |
C29367 | NCI drug code |
CHEMBL595 | ChEMBL Drug ID |
PIOGLITAZONE | GuideToPharmacology Ligand Name |
D03OFF | TTD Drug ID |